To asses this goal, we analyzed the immunohistochemical expression of c-KIT, CD34, CD31, CD105, smooth muscle actin (SMA), vascular endothelial growth factor (VEGF), and COX-2 in KS cells and performed a review of the relevant literature related to these aspects. This evidence concerns the gene SMN1 and Kaposi's sarcoma.